ArticleClinical, cosmetic and investigational dermatology2026
Efficacy and Safety of Intense Pulsed Light with Dual-Wavelength Spectra (555-950 nm and 530-750 nm) for Erythematotelangiectatic Rosacea Treatment in Chinese Patients.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Erythematotelangiectatic rosacea is characterized by central facial erythema and telangiectasia, accompanied by sensations of burning and stinging. Erythematotelangiectatic rosacea can be addressed through various treatments. We aimed to observe and evaluate the clinical effectiveness of a short pulse narrow-spectrum Intense pulsed light (IPL) with wavelength of 530-750nm and 555-950nm for the treatment of erythematotelangiectatic rosacea. Methods: We retrospectively collected patient information on erythematotelangiectatic rosacea and evaluated the clinical outcome. Results: 63 cases of erythematotelangiectatic rosacea were included. All patients received different sessions narrow spectrum IPL treatment with 555-950 nm and 530-750 nm filter combinations. The treatment efficacy rate was 57/63 (90.47%), all patients showed significant post-treatment Erythema Assessment Scale (EAS) levels reduction ( Conclusion: The narrow-spectrum IPL with 555-950nm and 530-750nm wavelengths filter combinations for the treatment of erythematotelangiectatic rosacea has the advantages of a high erythema improvement rate and low adverse reaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.